[Sjögren syndrome].
Tanaka
M
M
Department of Neurology & Clinical Research Center, National Nishi-Niigata Central Hospital.
Tanaka
K
K
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000974:Antibodies, Antinuclear; D017209:Apoptosis / Q000502:physiology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011379:Prognosis; D011976:Receptors, Muscarinic / Q000276:immunology; D012859:Sjogren's Syndrome / Q000209:etiology / Q000503:physiopathology
D000305:Adrenal Cortex Hormones; D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents; D011976:Receptors, Muscarinic